SomaScan™ 11K Assay is now Illumina SomaScan Discovery. Learn more.

Poster Download

A Proteomic Predictor of Conversion From Mild Cognitive Impairment to Dementia With Potential Utility in Enhancing Productivity of Emerging Clinical Trials